Cargando…
Effectiveness of the third dose of BNT162b2 vaccine on neutralizing Omicron variant in the Japanese population()
INTRODUCTION: The vaccine against SARS-CoV-2 provides humoral immunity to fight COVID-19; however, the acquired immunity gradually declines. Booster vaccination restores reduced humoral immunity; however, its effect on newly emerging variants, such as the Omicron variant, is a concern. As the waves...
Autores principales: | Kawasuji, Hitoshi, Morinaga, Yoshitomo, Tani, Hideki, Saga, Yumiko, Kaneda, Makito, Murai, Yushi, Ueno, Akitoshi, Miyajima, Yuki, Fukui, Yasutaka, Nagaoka, Kentaro, Ono, Chikako, Matsuura, Yoshiharu, Niimi, Hideki, Yamamoto, Yoshihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9186405/ https://www.ncbi.nlm.nih.gov/pubmed/35691864 http://dx.doi.org/10.1016/j.jiac.2022.05.009 |
Ejemplares similares
-
Age-Dependent Reduction in Neutralization against Alpha and Beta Variants of BNT162b2 SARS-CoV-2 Vaccine-Induced Immunity
por: Kawasuji, Hitoshi, et al.
Publicado: (2021) -
Neutralizing Antibody Response of the Wild-Type/Omicron BA.1 Bivalent Vaccine as the Second Booster Dose against Omicron BA.2 and BA.5
por: Kawasuji, Hitoshi, et al.
Publicado: (2023) -
Circulating Type I Interferon Levels in the Early Phase of COVID-19 Are Associated With the Development of Respiratory Failure
por: Nagaoka, Kentaro, et al.
Publicado: (2022) -
Effect of Casirivimab/Imdevimab Treatment on Serum Type I Interferon Levels in SARS-CoV-2 Infection
por: Nagaoka, Kentaro, et al.
Publicado: (2022) -
Correlation of the Commercial Anti-SARS-CoV-2 Receptor Binding Domain Antibody Test with the Chemiluminescent Reduction Neutralizing Test and Possible Detection of Antibodies to Emerging Variants
por: Morinaga, Yoshitomo, et al.
Publicado: (2021)